The fund seeks capital appreciation in the long term by investing in companies outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry.

These companies include, among others, pharmaceutical firms, medical supply companies, and businesses that operate hospitals and other health care facilities.

The team may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities.

Then the manager constructs a portfolio of stocks from a list of companies favored by the research team and allocates capital based on its conviction level.

The fund may invest up to 50% of its assets in foreign stocks.